Final Milestone on INS1007 | INSM Message Board Posts

Insmed Incorporated

  INSM website

  • TECH UPDATE: Since we don't serve ads to Premium Members, our "premium" URL is not affected by the new code now required by our ad partners. So, rather than wait for us to resolve all these lovely new code conflicts suddenly plaguing our free, ad-supported "www" pages  (a process which will likely take days), Premium Members can enjoy full site functionality now by simply logging in to their premium accounts at https://premium.investorvillage.com If you need password assistance, don't hesitate to contact us. That's what we're here for.  


INSM   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  46351 of 46881  at  6/17/2019 6:46:35 PM  by

b_leaguered


Final Milestone on INS1007

Note that $35 million is due to AstraZeneca only upon the achievement of $1 billion in ANNUAL sales, not ACCRUED sales. So if annual sales the first few years are below $1 billion, no payment will be due, say on $900 million. It speaks to the confidence AstraZeneca has that this will be at least a $1 billion a year seller, if approved. This is what W.L. hinted at in the GS conference.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 5     Views: 278
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...